“The Evaluation of Paclitaxel Effects on the Caco-2 Cell Line of Colon Cancer Patients”. Journal of Pharmaceutical Negative Results, Sept. 2022, pp. 459-63, https://doi.org/10.47750/pnr.2022.13.S01.56.